Zhou, L., Duan, P., Zang, P., Liang, C., Ye, J., Yan, Y., Zhang, S. (2026). Preliminary results from phase II enfortumab vedotin plus toripalimab compared to gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.782